scholarly article | Q13442814 |
P356 | DOI | 10.1093/HMG/5.9.1245 |
P698 | PubMed publication ID | 8872463 |
P50 | author | Julie M. Cunningham | Q67440680 |
Noralane Lindor | Q110912119 | ||
P2093 | author name string | M Schwab | |
S N Thibodeau | |||
P Goretzki | |||
A J French | |||
R Honchel | |||
K C Halling | |||
G Moslein | |||
D J Tester | |||
P433 | issue | 9 | |
P921 | main subject | colorectal cancer | Q188874 |
microsatellite | Q265193 | ||
colorectal carcinoma | Q25493920 | ||
P304 | page(s) | 1245-1252 | |
P577 | publication date | 1996-09-01 | |
P1433 | published in | Human Molecular Genetics | Q2720965 |
P1476 | title | Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer | |
P478 | volume | 5 |
Q83879723 | A 'nonsense' mutation leads to aberrant splicing of hMLH1 in a German hereditary non-polyposis colorectal cancer family |
Q54440242 | A new familial gastric cancer-related gene polymorphism: T1151A in the mismatch repair gene hMLH1. |
Q64389285 | A novel mutation avoidance mechanism dependent on S. cerevisiae RAD27 is distinct from DNA mismatch repair |
Q35753544 | Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences |
Q38360916 | Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing. |
Q58006247 | Clinical Definition of Hereditary Non-polyposis Colorectal Cancer: A Search for the Impossible? |
Q34099201 | Clinical and molecular analysis of hereditary non-polyposis colorectal cancer in Chinese colorectal cancer patients |
Q37222541 | Clinicopathological characteristics of colorectal cancer with family history: an evaluation of family history as a predictive factor for microsatellite instability |
Q45741007 | Colorectal cancer in Iran: immunohistochemical profiles of four mismatch repair proteins |
Q77983932 | Comparison of three methods of microsatellite detection |
Q35748966 | Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors |
Q34568596 | DNA mismatch repair defects: role in colorectal carcinogenesis |
Q35551054 | Diagnosis and Management of Hereditary Non-Polyposis Colon Cancer |
Q37235042 | Differences and evolution of the methods for the assessment of microsatellite instability |
Q47954900 | Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability |
Q34975498 | Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype |
Q33544969 | Effects of calcium and vitamin D on MLH1 and MSH2 expression in rectal mucosa of sporadic colorectal adenoma patients |
Q37236178 | Endometrial cancer as a familial tumor: pathology and molecular carcinogenesis (review). |
Q37797704 | Epigenetic Drivers of Genetic Alterations |
Q61196038 | Evaluation of the replication error phenotype in relation to molecular and clinicopathological features in hereditary and early onset colorectal cancer |
Q36641429 | Extensive molecular screening for hereditary non-polyposis colorectal cancer |
Q44169977 | Familial microsatellite-stable non-polyposis colorectal cancer: incidence and characteristics in a clinic-based population |
Q55018082 | Frameshift mutations and a length polymorphism in the hMSH3 gene and the spectrum of microsatellite instability in sporadic colon cancer. |
Q35594265 | Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients |
Q36083305 | Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae. |
Q33764029 | Genetic susceptibility to non-polyposis colorectal cancer |
Q36115550 | Genomic loci susceptible to replication errors in cancer cells |
Q64917220 | Genotype and phenotype in hereditary nonpolyposis colon cancer: a study of families with different vs. shared predisposing mutations |
Q54703701 | Genotyping possible polymorphic variants of human mismatch repair genes in healthy Korean individuals and sporadic colorectal cancer patients. |
Q40810320 | Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells |
Q44068446 | HNPCC mutations in hMSH2 result in reduced hMSH2-hMSH6 molecular switch functions |
Q34316225 | Hereditary non-polyposis colorectal cancer syndrome: combined risk of gastrointestinal and gynaecological cancer |
Q35597944 | Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer |
Q36060735 | Hereditary nonpolyposis colorectal cancer (Lynch syndrome): criteria for identification and management |
Q42037545 | Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations |
Q22009967 | Human exonuclease 1 functionally complements its yeast homologues in DNA recombination, RNA primer removal, and mutation avoidance |
Q36451916 | Human mismatch repair protein hMutLα is required to repair short slipped-DNAs of trinucleotide repeats |
Q24314329 | Identification and characterization of Saccharomyces cerevisiae EXO1, a gene encoding an exonuclease that interacts with MSH2 |
Q79073717 | Identification of germline MSH2 gene mutations in endometrial cancer not fulfilling the new clinical criteria for hereditary nonpolyposis colorectal cancer |
Q24628009 | Inherited colorectal cancer syndromes |
Q34579284 | Is reduced expression of mismatch repair genes MLH1 and MSH2 in patients with sporadic colorectal cancer related to their prognosis? |
Q58408875 | Le cancer du côlon: du diagnostic moléculaire à la conduite diagnostique et thérapeutique |
Q55242701 | Lung cancer early detection and health disparities: the intersection of epigenetics and ethnicity. |
Q34164054 | Lynch syndrome-associated mutations in MSH2 alter DNA repair and checkpoint response functions in vivo |
Q74323855 | MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer |
Q48386704 | MSI-L gastric carcinomas share the hMLH1 methylation status of MSI-H carcinomas but not their clinicopathological profile |
Q35619996 | Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1. |
Q61196002 | Methylation pattern of different regions of theMLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer |
Q57741879 | Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer? |
Q78087666 | Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers |
Q74180929 | Microsatellite instability and allelic imbalance in primary and secondary colorectal cancer |
Q53425970 | Microsatellite instability and aneuploidy rate in young colorectal-cancer patients do not differ significantly from those in older patients. |
Q57591251 | Microsatellite instability and hMLH1/hMSH2 expression in Barrett esophagus-associated adenocarcinoma |
Q42112990 | Microsatellite instability and mismatch repair gene inactivation in sporadic pancreatic and colon tumours |
Q87065266 | Microsatellite instability and promoter hypermethylation in colorectal cancer in India |
Q73554869 | Microsatellite instability in colorectal-cancer patients with suspected genetic predisposition |
Q74147673 | Microsatellite instability in sporadic carcinomas of the proximal colon: association with diploid DNA content, negative protein expression of p53, and distinct histomorphologic features |
Q36115031 | Microsatellite instability in squamous cell carcinomas of the head and neck related to field cancerization phenomena. |
Q58493764 | Microsatellite instability induced by hydrogen peroxide in Escherichia coli |
Q74290555 | Microsatellite instability is uncommon in young patients with renal cell carcinoma |
Q41686589 | Molecular biology of colorectal cancer |
Q30807030 | Molecular lesions in colorectal cancer: impact on prognosis? Original data and review of the literature |
Q73173931 | Multiple sites required for expression in 5'-flanking region of the hMLH1 gene |
Q28303186 | MutS homologs in mammalian cells |
Q38937353 | Novel hMSH2, hMSH6 and hMLH1 gene mutations and microsatellite instability in sporadic colorectal cancer |
Q73594059 | Optimising methods for determining RER status in colorectal cancers |
Q30444930 | Origin of microsatellite instability in gastric cancer |
Q59273299 | Pathogenicity of the hereditary colorectal cancer mutation hMLH1 del616 linked to shortage of the functional protein |
Q57591232 | Prevalence of germline mutations ofMLH1 andMSH2 in hereditary nonpolyposis colorectal cancer families from Spain |
Q34633911 | Prevalence of pathological germline mutations of hMLH1 and hMSH2 genes in colorectal cancer |
Q77899578 | Prognostic significance of microsatellite instability in sporadic mucinous colorectal cancers |
Q28303580 | Promoter methylation and immunohistochemical expression of hMLH1 and hMSH2 in sporadic colorectal cancer: a study from India |
Q35925613 | Promoter methylation of ITF2, but not APC, is associated with microsatellite instability in two populations of colorectal cancer patients. |
Q85155982 | Prospective Immunohistochemical Analysis of Primary Colorectal Cancers for Loss of Mismatch Repair Protein Expression |
Q36484887 | Recently identified colon cancer predispositions: MYH and MSH6 mutations |
Q34975833 | Review article: genetic testing and counselling for hereditary colorectal cancer |
Q36903207 | Risk of breast cancer in Lynch syndrome: a systematic review. |
Q36622905 | Role of chance in familial aggregation of colorectal cancer |
Q45150040 | Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL). |
Q41029452 | Search for chromosome instability in lymphocytes with germ-line mutations in DNA mismatch repair genes |
Q57741867 | The added value of PMS2 immunostaining in the diagnosis of hereditary nonpolyposis colorectal cancer |
Q37692625 | The dynamic DNA methylation landscape of the mutL homolog 1 shore is altered by MLH1-93G>A polymorphism in normal tissues and colorectal cancer |
Q34020549 | The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas |
Q34146408 | The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study |
Q37420429 | The identification of Lynch syndrome in British Columbia |
Q28274343 | The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer |
Q77467844 | The value of microsatellite instability in the detection of HNPCC families and of sporadic colorectal cancers with special biological features: an investigation on a series of 100 consecutive cases |
Q36246500 | Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome |
Q30588580 | Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer |
Q35788174 | hMLH1 promoter hypermethylation in microsatellite instability-positive endometrial carcinoma. Cause or consequence? |
Q36616145 | hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients |
Search more.